AC
Applied Clinical Trials
ACT Brief: APAC Sponsor Priorities, Continuous Glucose Monitoring Trials, and GLP-1 Eye Warning
0:00-1:52
In today’s ACT Brief, we examine three priorities for first-time APAC sponsors, how continuous glucose monitoring should be used in diabetes trials, and why FDA is requiring a new eye-related warning across GLP-1 medications.
Publisher
Applied Clinical Trials
Link
audioboom.com/posts/8975859
Published
November 12, 2026
Duration
2 min
Format
Podcast
Category
Issues · Science
Source
RSS feed
AC
Applied Clinical Trials
@appliedclinicaltrials
#apacsponsorpriorities #continuousglucosemonitoring #eyewarning #lifesciences
